相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program
Jovanka Gencel-Augusto et al.
CANCER DISCOVERY (2023)
The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute
Kelvin Cesar de Andrade et al.
CELL DEATH AND DIFFERENTIATION (2022)
Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies
Jian Tu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
Ori Hassin et al.
NATURE COMMUNICATIONS (2022)
WikiPathways: connecting communities
Marvin Martens et al.
NUCLEIC ACIDS RESEARCH (2021)
Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome
Brittany L. Jewell et al.
PLOS GENETICS (2021)
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
Hudie Wei et al.
NATURE COMMUNICATIONS (2021)
p53 tetramerization: at the center of the dominant-negative effect of mutant p53
Jovanka Gencel-Augusto et al.
GENES & DEVELOPMENT (2020)
Mutant p53 oncogenicity: dominant-negative or gain-of-function?
Yan Stein et al.
CARCINOGENESIS (2020)
ComBat-seq: batch effect adjustment for RNA-seq count data
Yuqing Zhang et al.
NAR GENOMICS AND BIOINFORMATICS (2020)
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Oleg Timofeev et al.
EMBO JOURNAL (2019)
Dysregulated Mitochondrial Dynamics and Metabolism in Obesity, Diabetes, and Cancer
Wenting Dai et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Sung-Hwan Moon et al.
CELL (2019)
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Kanaga Sabapathy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers
Chen Katz et al.
GENES & DEVELOPMENT (2018)
Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome
Nicholas W. Fischer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Grace R. Anderson et al.
NATURE COMMUNICATIONS (2018)
p53 and metabolism: from mechanism to therapeutics
Fernando M. Simabuco et al.
Oncotarget (2018)
Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome
Nicholas W. Fischer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
David E. Moulder et al.
CANCERS (2018)
Mouse Homolog of the Human TP53 R337H Mutation Reveals Its Role in Tumorigenesis
Ji-Hoon Park et al.
CANCER RESEARCH (2018)
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
Huensuk Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mutant p53 partners in crime
Michael P. Kim et al.
CELL DEATH AND DIFFERENTIATION (2018)
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Brandon J. Aubrey et al.
CELL DEATH AND DIFFERENTIATION (2018)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
A novel 3D in vitro metastasis model elucidates differential invasive strategies during and after breaching basement membrane
Asja Guzman et al.
BIOMATERIALS (2017)
KEGG as a reference resource for gene and protein annotation
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2016)
Risks of First and Subsequent Cancers Among TP53 Mutation Carriers in the National Cancer Institute Li-Fraumeni Syndrome Cohort
Phuong L. Mai et al.
CANCER (2016)
p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis
Nicholas W. Fischer et al.
CELL CYCLE (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Mitochondrial Dynamics and Metabolic Regulation
Timothy Wai et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
The Inherited p53 Mutation in the Brazilian Population
Maria Isabel Achatz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Alterations in Mitochondrial and endoplasmic Reticulum Signaling by p53 Mutants
Carlotta Giorgi et al.
FRONTIERS IN ONCOLOGY (2016)
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility
Marie-Helene Larraufie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Modeling Familial Cancer with Induced Pluripotent Stem Cells
Dung-Fang Lee et al.
CELL (2015)
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Jiajun Zhu et al.
NATURE (2015)
MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs
Qingguo Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
p53 and mitochondrial function in neurons
David B. Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Steven Lin et al.
ELIFE (2014)
Mitochondrial death functions of p53
N. D. Marchenko et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Activation and control of p53 tetramerization in individual living cells
Giorgio Gaglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tumour-associated mutant p53 drives the Warburg effect
Cen Zhang et al.
NATURE COMMUNICATIONS (2013)
RhoGAPs Attenuate Cell Proliferation by Direct Interaction with p53 Tetramerization Domain
Jie Xu et al.
CELL REPORTS (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Mutant p53 cooperates with ETS2 to promote etoposide resistance
Phi M. Do et al.
GENES & DEVELOPMENT (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation
Gabriel S. Macedo et al.
PLOS ONE (2012)
Mitochondrial Fission, Fusion, and Stress
Richard J. Youle et al.
SCIENCE (2012)
Mitochondrial Fission Induces Glycolytic Reprogramming in Cancer-Associated Myofibroblasts, Driving Stromal Lactate Production, and Early Tumor Growth
Carmela Guido et al.
ONCOTARGET (2012)
The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein
Michela Muscolini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Detailed Haplotype Analysis at the TP53 Locus in p.R337H Mutation Carriers in the Population of Southern Brazil: Evidence for a Founder Effect
Sonia Garritano et al.
HUMAN MUTATION (2010)
BclxL Changes Conformation upon Binding to Wild-type but Not Mutant p53 DNA Binding Domain
Franz Hagn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mitochondrial fission/fusion dynamics and apoptosis
Clare Sheridan et al.
MITOCHONDRION (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
The mitochondrial p53 pathway
Angelina V. Vaseva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Cytoplasmic functions of the tumour suppressor p53
Douglas R. Green et al.
NATURE (2009)
Influence of tetramerisation on site-specific post-translational modifications of p53
Lorna J. Warnock et al.
CANCER BIOLOGY & THERAPY (2008)
p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity
Sonja Wolff et al.
CELL RESEARCH (2008)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis
Andrea Ivascu et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation
Evguenia Strom et al.
NATURE CHEMICAL BIOLOGY (2006)
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization
Y Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library
T Kawaguchi et al.
ONCOGENE (2005)
Mitochondrial fission in apoptosis
RJ Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex
JIJ Leu et al.
NATURE CELL BIOLOGY (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Cooperative binding of tetrameric p53 to DNA
RL Weinberg et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers - Implications on the dominant negative effect
CD Nicholls et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1
J Sampath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The role of tetramerization in p53 function
P Chène
ONCOGENE (2001)
分享论文
